在Mycobacterium结核病的异化物标的晶体结构和功能
A Dessen1, A Quémard, J S Blanchard
1Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461.
概括
结核病中异化物耐药性与InhA蛋白的突变有关,影响其结合NADH的能力. InhA酶的这种结构变化通过改变必需脂肪酸合成来阻碍药物的疗效.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物耐药性机制 药物耐药性机制
背景情况:
- 结核病 (TB) 仍然是全球主要的健康威胁,耐药性使治疗复杂化.
- 伊索尼亚是第一线抗结核病药物,耐药性显著影响治疗结果.
- InhA蛋白是异化的关键点,它参与了Mycobacterium tuberculosis中的必需脂肪酸生物合成.
研究的目的:
- 阐明Mycobacterium tuberculosis中异化物耐药性的基础分子机制.
- 研究InhA蛋白中突变的结构和功能后果.
- 了解InhA中改变的NADH结合是如何导致药物耐药性的.
主要方法:
- 使用X射线晶体学来确定野生型和突变的InhA蛋白质的三维结构.
- 进行了动力学分析,以评估酶活性和基质结合 afinities.
- 生物化学试验被用来研究InhA,NADH及其基质之间的相互作用.
主要成果:
- 在InhA中,一种特定的突变 (Ser94Ala) 被确定为异化物耐药性的媒介.
- 突变的InhA蛋白对β-尼古丁胺胺腺因二核酸 (NADH) 的亲和力降低.
- 结构分析显示,这种突变扰乱了对稳定NADH与InhA结合至关重要的结网.
结论:
- 在InhA中的Ser94Ala替代直接通过破坏NADH结合来赋予异化物耐药性.
- 了解这些结构功能关系对于制定新的抗结核战略至关重要.
- 准InhA及其与NADH的相互作用为克服异化物耐药性提供了一个潜在的途径.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
相关概念视频
Protein and Protein Structure
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
A protein's shape is critical to its function. For example, an enzyme can...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Bacterial Phylum Actinobacteria
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
